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Abstract
The dissolution or melting of a crystalline drug into a molten polymeric matrix underpins the 
fabrication of a number of drug delivery systems. However, little is known about how crystals 
dissolve in such viscous matrices. Herein, the heat-induced dissolution of indomethacin crystals 
into a molten polymer, copovidone, was evaluated, probing changes in crystal features at 
multiple length scales using various microscopy techniques. Diffusion of the drug into the 
polymer film was observed by elemental composition analysis (scanning electron microscopy 
with energy-dispersive X-ray analysis). Under polarized light microscopy, irregular dissolution 
patterns were observed, in which channels and holes were seen forming in the crystals, which 
then resulted in fragmentation. At shorter length scales by scanning and transmission electron 
microscopy (SEM and TEM), crystals demonstrated a range of channel formation and 
fragmentation behaviors. Defect sites intrinsic to the bulk crystals were hypothesized to be the 
origin of the dissolution-induced fragmentation process. A defect site-driven dissolution and 
fragmentation model was thus proposed. A Monte Carlo simulation of crystal dissolution under a 
range of surface energy configurations is also presented. This study has implications for 
modeling and understanding of dissolution kinetics and pathways of organic crystals in the 
context of processing operations such as hot melt extrusion.
Keywords
Crystal dissolution; polymer; diffusion; fragmentation; amorphous; defects
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Introduction
Crystal dissolution is a fundamentally important process, but is typically studied only by 
evaluating the rate of appearance of molecules in the solution phase,1 with little attention paid to 
the evolving structure of the dissolving crystal.2,3 This oversight potentially leads to erroneous 
conclusions about dissolution mechanisms and the implementation of theoretical models that do 
not appropriately capture dissolution kinetics. In comparison to the body of experimental and 
theoretical data on crystal growth,4,5 crystal dissolution kinetics and mechanisms are less well 
understood.6,7
One area where dissolution mechanisms have received little attention is the dissolution of 
organic crystals into polymers. Polymers are used as functional excipients in pharmaceutical 
formulations ranging from controlled release delivery systems,8–10 mucoadhesives,11,12 
nanosuspensions/nanoparticles,13–15 biopharmaceuticals,16 transdermal systems,17 and solid 
dispersions.18–21 Thermal-based processing, such as hot melt extrusion (HME), has been used 
manufacture drug-polymer systems for a wide range of formulation applications, including 
controlled release,22–24 taste masking,25 implants,26,27 and solubility enhancement.28,29
The dissolution of crystals into polymers is particularly relevant for hot melt extrusion 
processing to produce amorphous solid dispersion (ASD) drug formulations.30–32 Amorphous 
systems are of great interest as a formulation strategy to address low drug solubility.33–35 By 
dispersing the drug within an amorphous polymer to produce a single phase amorphous blend, a 
system kinetically stable against crystallization can be produced.19,36,37 During hot melt extrusion 
processing, the goal is to transform a powder blend of crystalline drug and amorphous polymer 
into a single phase, homogenous melt using thermal and mechanical input.38,39 If performed 
above the drug’s melting point, the transformation can be described as melting, followed by 
mixing of liquid drug and polymer. If performed below the drug’s melting point, the polymer can 
act as a solvent, allowing the drug to dissolve into the highly viscous matrix.32 The dissolution 
process of crystalline drug into polymer melt has been mathematically described by the Noyes-
Whitney equation, where dissolution is governed by crystal surface area, solute diffusivity, and 
solubility.31,32,40,41 This, however, neglects contributions from drug crystal properties (e.g. 
defects) or contributions from the mechanical process (e.g. crystal breakage) on the dissolution 
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rate. Despite the practical relevance to the formation of ASDs through the HME process, there is 
a lack of knowledge around the mechanism of crystal dissolution into polymer melts.
Imperfections and local disorder at crystal surfaces and in the bulk are common in organic 
crystals, originating during crystallization or other downstream processing operations.42–45 Such 
defects, in the form of vacancies, impurities, dislocations, and grain boundaries, are sites of 
higher energy and greater molecular mobility, and may contribute to the initiation of physical or 
chemical transformations, such as melting, solubilization, polymorphic transitions, or mechanical 
failure.43 Crystal defects have been linked to increased dissolution rates.46–49 Local stress fields 
in solids result from virtually all types of reactions, and therefore have important chemical and 
physical consequences.50–52 Defects have also been shown to impart localized stress, helping to 
explain their role in enhancing dissolution rates and facilitating physical or chemical 
transformations.53 Crystal faces are known to dissolve at different rates in aqueous solution,2,3 
although most dissolution models typically assume a spherical particle shape.54–57 Various efforts 
to study crystallization using Monte Carlo simulations have also revealed the potential for 
imperfections through the course of crystallization in the form of surface roughening of growing 
crystal faces.58,59 These imperfect surfaces are known to exhibit a greater surface energy than 
their smooth counterparts, as well as heterogeneities in surface energy distribution.60–62 Monte 
Carlo simulations have also been used to simulate the statistical processes associated with 
dissolution of minerals and amorphous solids, highlighting etch pit formation and irregular 
dissolution associated with defects and surface heterogeneities.63–66
Recently, we reported the existence of nanometer-scale residual crystals within a nominally 
crystal-free hot melt extruded amorphous solid dispersion.67 These residual crystals were found 
to contain a range of defects, which we hypothesized had both intrinsic and mechanical origins. 
Additionally, preliminary evidence of a fragmentation-based dissolution mechanism was 
observed; however, given the high mechanical input of the HME process, other explanations are 
also possible. The goal of this study was to explore the dissolution of drug crystals into molten 
polymer under quiescent conditions, to better understand the crystal-to-solution transformation in 
the absence of mechanical input, addressing the hypothesis that crystal fragmentation occurs in 
addition to diffusion-based crystal shrinkage. Copovidone films with suspended indomethacin 
crystals were heated under quiescent isothermal conditions, at a temperature below the drug’s 
melting point, to initiate the crystal dissolution process. By monitoring changes under multiple 
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length scales, effects of crystal properties and microstructure on the dissolution mechanism were 
captured. A Monte Carlo simulation of crystal dissolution under a range of surface energy 
configurations is also presented. We believe this study is the first to investigate the mechanism of 
crystal dissolution into a polymer melt and to report a fragmentation-based microstructural 
progression.
Experimental Section
Materials
Indomethacin (IDM, Tm = 161°C) was obtained from ChemShuttle (Hayward, CA). 
Copovidone (polyvinylpyrrolidone/vinyl acetate copolymer, Kollidon VA64, Tg = 104°C) was a 
gift from BASF (Florham Park, NJ). Chemical structures and elemental composition are 
provided in Figure 1a. Relative elemental composition refers to the calculated atomic % of the 
overall composition without hydrogen. The IDM powder has a particle size D50 of 
21.9 ± 0.3 μm (Figure 1b), determined in triplicate using a Malvern Mastersizer 3000 particle 
size analyzer with Aero S attachment (Worcestershire, UK).
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Figure 1. (a) Chemical structures and relative elemental composition of indomethacin and 
copovidone. (b) Particle size distribution of indomethacin crystals.
Experimental Methods
X-Ray Diffraction (XRD)
Films composed of copovidone and suspended indomethacin (IDM) crystals (5:1 ratio) were 
deposited from water onto a zero background silicon sample plate. X-ray diffraction patterns 
were recorded using a Panalytical Empyrean diffractometer (Malvern, United Kingdom) with a 
Cu-kα radiation source and PIXcel3D detector equipped with an Anton Paar HTK 1200N high 
temperature chamber (Graz, Austria). Prior to heating, an ambient scan of the film was collected. 
After heating to 130°C over approximately 10 minutes, patterns were obtained from 10-30° 2θ 
over 15 minutes and monitored up to 3 hours.
Polarized Light Microscopy (PLM)
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Films composed of copovidone and suspended indomethacin (IDM) crystals (5:1 ratio) were 
deposited from water onto glass slides. Films were held at 130°C for up to 3 hours on an 
integrated hot stage. During heating on the hot stage, images of the drug crystal dissolution 
process were periodically captured using a Nikon Eclipse E600 POL cross-polarized light 
microscope (20X objective) with Nikon DS-Ri2 camera (Melville, NY).
Scanning Electron Microscopy (SEM)
The glass slides from the polarized light microscopy investigation containing the heat-treated 
films were then fixed on SEM stubs and sputter-coated with platinum for 60 seconds. Imaging 
was performed with an FEI Nova nanoSEM field emission scanning electron microscope (FEI 
Company, Hillsboro, Oregon) operated at 10 kV accelerating voltage, ∼6 mm working distance, 
and a spot size of 5. Secondary electron images were captured with the Everhart Thornley 
detector (ETD) and backscatter electron images were collected using a vCD detector. 
To collect elemental data, a ∼10 mm working distance and an X-Max energy-dispersive X-
ray (EDX) detector was used. The resulting data was analyzed with an Oxford Aztec system 
(Oxford Instruments, Abingdon, Oxfordshire, UK). The QuantMap and QuantLine functions 
were used to calculate elemental composition (atomic %).
Transmission Electron Microscopy (TEM)
Films composed of copovidone and suspended indomethacin crystals (5:1 ratio) were 
deposited from water onto glow-discharged 300 mesh carbon-coated copper TEM grids with 5-
6 nm standard thickness (SPI supplies, West Chester, PA). Films were held at 130°C for up to 
3 hours on a hot stage (integrated with the polarized light microscope). An FEI Tecnai G20 
electron microscope (FEI, Hillsboro, Oregon, USA) equipped with a LaB6 source, X-max 
80 mm2 silicon drift detector (Oxford Instruments, Abingdon, Oxfordshire, UK), and Gatan 
US1000 2kx2k bottom mount CCD camera, operated at 200 keV, 100 µm aperture, and a spot 
size of 1, was used to acquire bright-field transmission electron micrographs. At least three grid 
squares were analyzed to ensure particles characterized were representative of the overall 
sample.
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Fast Fourier Transform (FFT) analysis was performed using the Gatan DigitalMicrograph 
3.21 software suite (Pleasanton, CA). Fourier filtering was applied using a spot mask symmetric 
about the origin of the FFT image, which selects only the desired frequencies (in reciprocal 
space). By then performing an inverse FFT on the masked image, the filtered image is 
reconstructed (in real space) which reveals only the periodic content associated with the specific 
FFT spot pair, not necessarily the atomic columns associated with the crystal. ImageJ 1.51 
(National Institutes of Health, Bethesda, MD) was used to apply false color imaging and prepare 
overlays.
Computational Methods
Monte Carlo Simulation
Two-dimensional lattice Monte Carlo (MC) simulations were performed in order to model 
experimental dissolution observations. An initial grid was populated with crystalline sites 
whereby allowed trial moves consisted of removing crystal sites from the lattice at random. The 
probability of accepting or rejecting these moves was determined by the change in energy 
associated with adding or removing interfacial area, where the formation of new interfaces is 
considered energetically unfavorable. Furthermore, the underlying surface energy distribution of 
the lattice was also tuned to describe the heterogeneities that may be found in real crystals. 
Mathematically, the probability for accepting a trial move is expressed as (Eq.:
 ( ) exp surface interfacesP x E E       (Eq. 1)
Here, P(x) is the probability of accepting a trial move, Esurface is the underlying surface energy of 
the trial site, and ΔEinterfaces is the energy change from adding or removing the total number of 
interfaces. Once P(x) is determined, it is compared to a random number between 0 and 1 taken 
from a uniform distribution; if P(x) is greater than or equal to the random number the trial move 
is accepted, and if P(x) is less than the random number the trial move is rejected. The simulation 
is allowed to continue until no crystalline units remain. The dimensionless energy penalty 
associated with each new interface was chosen to be 4.0 to allow simulations to progress in a 
reasonable timeframe. Computer code was written in Python and made use of NumPy68 and 
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Matplotlib69 libraries for mathematical functions and visualization of results, respectively 
(available as supplementary data).
Results
Characterization of Bulk Drug Crystals
Based on characterization by multiple microscopic techniques, the bulk IDM crystals were 
found to consist of plate-like single crystals, with small crystals adhered to the generally smooth 
surface.67 Additionally, surface imperfections and irregular growth are evident (Figure 2a,b). 
When distributed in a copovidone film deposited from water, the plate-like nature of the bulk 
crystals with associated surface crystals can still be observed (Figure 2b,c).
Figure 2. SEM and PLM images of (a) indomethacin crystals with surface imperfections, 
and (b,c) IDM crystals distributed in a copovidone film. The time notation in (b) and (c) 
refers to the duration of isothermal heating of the crystal in the polymer film (in this case 
no heating).
By imaging small indomethacin crystals with transmission electron microscopy (Figure 3), 
microstructure as well as the impact of the polymer film on the crystals can be observed. A drug 
crystal (no polymer film) has consistent internal microstructure, and gradual thickness changes 
as well as layers of crystal growth can be observed. The indomethacin crystal (dispersed in a 
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copovidone film without heating) shown in Figure 3b shows the same smooth transition of 
thickness variation. In Figure 3c, grain boundaries divide a flat crystal into three distinct regions. 
During the imaging of this particle, the diffraction contrast from each region moved 
independently when focus was changed, confirming the crystallinity of the particle, as well as the 
different orientation of the three regions. In Figure 3d, thickness variations can again be 
observed, as well as discrete crystallites on the surface of the parent crystal. The presence of 
these surface crystallites and strain at the crystal-polymer interface leads to bend contours.
Figure 3. Bright field TEM images of (a) the internal microstructure of an indomethacin 
crystal, and (b-d) IDM crystals distributed in a copovidone film. The time notation in (b-d) 
refers to the duration of isothermal heating of the crystal in the polymer film (in this case 
no heating).
Dissolution of Drug Crystals in Polymer Films
Drug-Polymer Dissolution Monitored by Variable Temperature X-ray Diffraction
High temperature X-ray diffraction (XRD) has been used to study reaction kinetics and solid 
state changes,70–72 and was used herein to monitor the in situ dissolution of indomethacin into 
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molten copovidone under quiescent isothermal conditions. By heating the physical mixture to 
130°C and monitoring the profile as the crystal dissolves into the polymeric matrix (Figure 4), 
the crystalline peak heights can be observed to decrease over time. The peak pattern at 130°C 
matches that of the physical mixture at room temperature, although a small shift can be observed 
attributable to the temperature difference. The detectable crystalline phase at the 20.7° 2θ has 
disappeared at approximately 120 minutes. Detectability of the crystalline phase may be limited 
by dilution of drug by the polymer, crystallite size, and crystal quality.67,73–77
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Figure 4. XRD patterns of indomethacin crystals dispersed in a copovidone film at ambient 
conditions and as the crystals dissolve over time at 130°C.
Polarized Light Microscopy
Indomethacin crystals distributed in a copovidone film were held under quiescent isothermal 
conditions at 130°C and crystal dissolution into the molten polymer was observed with time. The 
dissolution of three individual crystals under polarized light is shown in Figure 5. The smallest 
crystals dissolve quickly in under 30 minutes, leaving the larger crystals to be observed. 
Crystal A breaks up into at least 5 pieces within 30 minutes of isothermal treatment (black 
arrows), and then each of those individual fragments dissolve over the observation period. 
Crystal B shows evidence of an apparent growth imperfection to the crystal structure (blue 
arrows, also shown in Figure 2b). This disruption grows and separates the crystal into two pieces 
within 15-30 minutes. The small fragment dissolves within 60 minutes of observation, while the 
larger fragment continues to dissolve during the observation period. A channel can be seen 
Page 11 of 40
ACS Paragon Plus Environment
Crystal Growth & Design
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Page 12 of 40
forming from the left side of the crystal at around 45 minutes (white arrows), and irregularly 
grows as the crystal dissolves, ultimately dividing the fragment into two pieces around 
105 minutes. Additionally, holes can be seen forming around 60 minutes in the center of crystal 
fragments which grow during the dissolution process. Similar to crystal B, a hole forms in 
crystal C around 30 minutes (purple arrows), which enlarges as dissolution continues. Because of 
the proximity of the hole to the edge of the crystal, the hole eventually merges with the 
amorphous matrix. In each image series, a boundary appears around the crystal where dissolved 
drug has joined the molten phase. This suggests that there is a refractive index difference to this 
area of film caused by a change in chemical composition and/or film thickness as the diffused 
drug migrates through the polymer melt.
Figure 5. Time lapse polarized light micrographs of indomethacin crystals dissolving into 
copovidone held at 130°C. Arrows note the appearance and progression of hole and 
channel formation and fragmentation (discussed in the text).
Scanning Electron Microscopy
Copovidone films containing partially dissolved indomethacin crystals were observed by 
SEM, equipped with a backscatter detector. Crystals appear lighter (greater intensity) than the 
surrounding film, which indicates higher atomic number, presumably due to the chlorine atoms 
present in indomethacin. While the bulk crystals had generally smooth surfaces (Figure 2a), the 
partially dissolved crystals show irregular patterns on the crystal surface due to partial 
dissolution, as in Figure 6a. Figure 6b shows a small crystallite with channel formations prior to 
significant dissociation. In Figure 6c, the crystal fragments are found below the film surface, 
while they are found at the film surface in Figure 6d.
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Figure 6. Backscatter SEM images of indomethacin drug crystals at various stages of 
dissolution into copovidone melt. The time notation refers to the duration of isothermal 
heating of the crystal in the polymer film (in this case 1 or 2 hours at 130°C).
The diffusion process was observed in crystals before (Figure 7a) and after heating and 
dissolution (Figure 7b) using elemental mapping. Indomethacin contains chlorine, while 
copovidone does not contain any unique elements. Thus, the appearance of chlorine indicates the 
presence of indomethacin, either as a crystal or molecularly dissolved into the film. Across the 
mapped area of the near-completely dissolved crystal (Figure 7b), a region of higher intensity in 
the backscattered image is observed around the remnants of a crystal which can be attributed to 
the presence of chlorine. The elemental mapping shows slight modulation of carbon, oxygen, and 
nitrogen signals in the polymer and drug-polymer diffusion areas, while distinct chlorine signals, 
corresponding to the increased intensity region in the electron image, are observed. A line scan 
was taken to provide elemental composition information across the region of interest, in the 
polymer, drug-polymer diffusion, and crystal regions. Carbon, oxygen, and nitrogen show the 
expected trends of change in elemental composition across the line scan, based on consideration 
of the relative elemental compositions of drug and polymer. Interestingly, oxygen shows a 
distinct drop in quantity at the location of the crystal, corresponding to the lower overall oxygen 
content found in indomethacin relative to copovidone. In the outer areas of the film, no chlorine 
is detected indicating that only polymer is present. Moving inward, chlorine then appears and 
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increases in concentration, maximizing across the majority of the drug-polymer diffusion and 
crystal regions. Due to the penetration depth of the electron beam, signal from the amorphous 
matrix is also seen in the area of the crystal, so the overall chlorine content appears lower than 
the theoretical level of a pure indomethacin crystal. In the undissolved crystal (Figure 7a), 
appearance of chlorine is observed which identifies the crystal in the film. No signal from 
indomethacin is seen outside of the crystal.
Figure 7. (a) SEM image and elemental maps and linescan of an undissolved crystal in the 
copovidone film. Distinct appearance of chlorine identifies the crystalline material. (b) 
Backscatter SEM image and elemental maps and line scan of a near completely dissolved 
indomethacin crystal into the copovidone film. The region of greater intensity surrounding 
the crystal (identified by a white arrow) indicates the change in atomic composition due to 
the diffusion of indomethacin into the polymer melt. Small modulations in carbon, oxygen, 
and nitrogen content across the map are observed, while distinct appearance of chlorine 
content is found in the diffusion area. The location of the line scan on the rotated SEM 
image is presented, and aligns with the scale on the panels shown in the chart. Vertical 
dashed lines indicate the location of the crystal and diffusion areas along the line scan. The 
time notation refers to the duration of isothermal heating of the crystal in the polymer film 
(in this case no heating or 1 hour at 130°C).
Transmission Electron Microscopy
TEM images allow the overall morphology and internal structure of the crystal to be 
visualized within the film following the heating process. However, the inherent challenge with 
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this technique is in preparing an electron-transparent sample on the order of 100 nm thickness.78–
80 Amorphous domains appear as a homogenous continuous phase, while evidence of 
crystallinity include darker areas within the matrix, diffraction contrast, and lattice planes (at 
high magnification only).67,81–84 Due to thickness variations of the crystal and film deposited on 
the grid and interference from the amorphous matrix, the crystal lattice could only be visualized 
in some crystalline regions. When lattice planes can be visualized, crystallinity can be confirmed 
by Fast Fourier Transform (FFT) analysis.67
Bright field TEM images capture the stages of channel formation and fragmentation in the 
crystalline particles shown in Figure 8. Each of these particles has a rounded shape, indicating 
fairly uniform dissolution and reduction in crystal size by dissolution at all crystal surfaces. 
Figure 8a shows an example of the initiation of channel formation, where the channel has 
advanced <20 nm into the crystal. A more extensive channel, where the particle is fully divided, 
can be seen in Figure 8b. At an even more advanced stage of dissolution, separate fragments, 
presumably originating from a single particle with extensive channel formation, can be observed 
(Figure 8c). In each of these crystallites, the crystal lattice could not be imaged due to sample 
thickness and/or crystal orientation; however, crystallinity can be confirmed by the presence of 
diffraction contrast.
Figure 8. Bright field TEM images of indomethacin crystals with increasing degrees of 
channel formation and fragmentation. The arrows indicate channels where amorphous 
content is advancing into the crystal, dividing crystalline areas. The time notation refers to 
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the duration of isothermal heating of the crystal in the polymer film (in this case 30 minutes 
at 130°C).
The intermediate stages of channel formation (Figure 9) were captured in a single particle, 
similar to what was seen under time lapse imaging with polarized light microscopy (Figure 5). A 
larger parent crystal (Figure 9a) has dissociated into three large fragments. Two of the smaller 
daughter fragments are separated by a narrow channel (Figure 9b), indicating they have more 
recently dissociated. Several small channels evolving from the left and right sides of the crystal 
are highlighted in Figure 9b. The channels at the bottom of the particle (Figure 9c) are nearly 
connected, whereby completion would eventually lead to crystal breakage. In Figure 9d, greater 
extent of dissolution is seen at the edge of the particle where the channel initiated; the channel 
becomes narrower as it advances into the particle. The heterogeneous appearance can be 
attributed to thickness variations across the crystal, as well as scattering effects from defects 
induced by the dissolution of the crystal.
Figure 9. Bright field TEM images of indomethacin crystals with channel formations. The 
arrows indicate channels where amorphous content is advancing into the crystal, dividing 
crystalline areas. The time notation refers to the duration of isothermal heating of the 
crystal in the polymer film (in this case 3 hours at 130°C).
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At a later stage of dissolution, a fragment field consisting of small, connected crystalline 
domains is observed (Figure 10a). Channels and wider regions of amorphous material are 
observed in interior areas. The highlighted region contains many crystallites, as noted by the 
presence of many spots at the same distance from the center of the FFT pattern (indicating that 
the spots arise from the same lattice spacing), but at multiple orientations (Figure 10b,inset). In 
this region, a channel is found which has separated a crystal fragment into two areas. The false 
color reconstruction was created from a single FFT spot, demonstrating a crystal lattice of a 
single orientation and lattice spacing (Figure 10c). Thus, this crystallite, now divided, has not 
changed orientation or position as it is dissolving and breaking into two pieces. This observation 
provides evidence that the fragments are derived from a parent crystal.
Figure 10. Bright field TEM images of a crystal fragment field of indomethacin crystals 
dissolving into a copovidone film at a later stage of dissolution (a). A channel has formed 
which separates two areas of a crystal fragment (b), highlighted by the false color 
reconstruction (c) generated from a single FFT spot (b, inset). The time notation refers to 
the duration of isothermal heating of the crystal in the polymer film (in this case 3 hours at 
130°C).
Global dissolution by diffusion results in particle shrinkage, where the crystal dissolves from 
all surfaces. This is evidenced in Figure 11a, wherein a 40 nm crystallite with rounded shape has 
a single crystal lattice plane in focus throughout the entire area (Figure 11b), except in the lower 
right corner, where the lattice is obscured due to crystal thickness. 
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Figure 11. Bright field TEM images showing the dissolution by particle shrinkage (a-b) and 
fragmentation (c-f) mechanisms. In the crystallite in (a), the FFT pattern (a, inset) was 
reconstructed to reveal single lattice spacing. In the particle in (c), the four distinct spots 
with equivalent lattice spacing in FFT pattern (d) were reconstructed (e) to reveal a series 
of fragmentation and rotation events. The rotation of each false colorized lattice spacing is 
shown in (f). The time notation refers to the duration of isothermal heating of the crystal in 
the polymer film (in this case 2 hours at 130°C).
In Figure 11c, the mechanism of fragmentation of a 30 nm crystallite is observed. The FFT 
pattern shows four distinct spots with equivalent lattice spacing, which were individually 
reconstructed and false colorized with red, blue, yellow, and green. The spot indicated in blue is 
the sharpest, indicating that this is likely the original orientation of this lattice plane which has 
not shifted. The spot marked in red appears more as a smear rather than a crisp FFT spot, 
indicating slightly different orientation of areas of the lattice. The red fragment has rotated 
roughly 6° from the original placement, but covers approximately the same area in the x-y plane 
as the blue fragment. The red and blue lattice fragments are slightly obscured in the center due to 
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crystal thickness. The spots marked in yellow and green cover roughly the same area in the x-y 
plane, but are approximately 8° and 12° shifted from the blue fragment. The overlay of these 
fragments reveals the layer-like structure of the crystal. Due to the size and spatial placement of 
each of the four fragments, there are three fragmentation sites where the crystal has delaminated 
or split apart. The first fragmentation site splits the yellow/green and red/blue fragments into top 
and bottom pieces. The red/blue and yellow/green fragments delaminated in the z-axis (i.e. 
parallel to the x-y plane). Rotation of each fragment presumably occurs as a result of slow 
dynamic motion of the crystallites in the amorphous matrix, diffusive movement of 
indomethacin into the amorphous matrix, and diffusive movement of copovidone into the area of 
the crystal, which functions to push the fragments apart. The crystal fragments, from red to 
green, rotate over a total of 18.8°.
When the crystal surface has dissolved sufficiently, discrete crystallites within the overall 
structure can be identified. In Figure 12, two daughter fragments of 150-300 nm in size are 
separated by a channel distance of 5 nm, suggesting their origin from a single parent crystalline 
particle. In each of these fragments, narrow channels can be seen penetrating from the edges and 
within the particulate structure (highlighted by the arrows in Figure 12b). These internal channels 
curve around crystalline formations. In Figure 12c, through FFT analysis, the lattice structure of 
the darker formations identifies crystalline domains of 6.4 ± 2.2 nm (n=18) in size. The 
consistent lattice spacing indicates that a single lattice plane is being observed with multiple 
orientations. There are two possibilities for such an observation: (1) a parent crystal has 
fragmented, and the resultant crystallites have rotated in the x-y plane, or (2) the parent crystal 
was made up of multiple crystal orientations, which have now separated due to the dissolution 
process. Indeed, the crystallites in both daughter fragments are oriented primarily in the 1st/3rd 
quadrant, and have a maximum rotation of 93°. Movement of the crystallites may also have 
taken place as a result of the cooling process from 130°C to room temperature.
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Figure 12. Bright field TEM images of an indomethacin crystal fragmented into two 
fragments 150-300 nm in size (a). Channel formations are observed (b), as well as discrete 
crystallites having rotated within the structure (c). False colorized reconstructions were 
generated from each FFT spot, with the crystallites spatially identified A-H corresponding 
to the FFT spot. The time notation refers to the duration of isothermal heating of the 
crystal in the polymer film (in this case 3 hours at 130°C).
Time Progression of Crystal Dissolution
Observation of crystalline material and its corresponding microstructure by TEM is 
inherently limited by the thickness requirement of the sample. In many of the images presented 
(Figure 8, Figure 11), even when lattice planes were visualized in one area, thickness variations 
obscured part of the crystalline area. Films were prepared and observed up to 3 hours of 
quiescent isothermal heating, and a different population of crystalline material would be 
expected to be observed at each time point, based on an extent of dissolution that translated to 
the specific thicknesses required for observation. While the dissolution mechanism is not 
expected to change overall based on the length of time, the observations that can be captured 
vary based on initial crystal size.
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At an early time point (30 minutes), crystalline material from the smaller initial particles 
would be observable. For example, in Figure 8, the channel formation and fragmentation process 
is captured where the total area observed ranges from 100-300 nm. After 2 hours, the 
microstructure of 30-40 nm discrete crystals was observed (Figure 11), showing particle 
shrinkage and fragmentation dissolution mechanisms. After 2 and 3 hours, the highly 
heterogeneous nature of the particle surfaces could be observed in larger fragments (for example, 
Figure 9, Figure 10b, Figure 12). Discrete crystalline domains could be observed, as well as 
orientation changes.
At later time points, collections of small fragments are observed by both TEM and SEM 
techniques (Figure 10b, Figure 13). Because of the spatial proximity and similarity in extent of 
dissolution, these regions likely originated from a single particle, which has dissolved through 
the diffusion, particle shrinkage, channel formation, and fragmentation mechanisms. The 
particles do not migrate significantly from one another due to slow diffusivity in the highly 
viscous matrix. These fragment fields are seen over larger areas in SEM than can be observed in 
TEM due to the instrumental limitations of each technique. However, both techniques 
demonstrate the creation of new interfaces due to irregular dissolution, channel formation, and 
fragmentation.
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Figure 13. Crystal fragment fields observed by TEM (a-d) and SEM (e-f). Due to spatial 
proximity, and similarity in extent of dissolution, these regions likely originated from a 
single particle. The time notation refers to the duration of isothermal heating in the crystal 
in the polymer film (in this case 1-3 hours at 130°C).
Monte Carlo Simulation of Crystal Dissolution
Monte Carlo simulations of the probability of crystal dissolution were performed for systems 
representing various surface energy configurations. Figure 14 depicts three sample surface 
energy distributions with snapshots of the accompanying simulations. Figure 14a shows a 
uniform surface energy, representative of an ideal, defect free crystal. Figure 14b is a surface 
energy configuration containing a long diagonal region of high surface energy, representing the 
surface energy of a grain boundary between two crystallites. Figure 14c is more complex, 
containing randomly placed two-dimensional Gaussians of high surface energy along with two 
orthogonal lines originating from each of these high energy centers. The orientations of these 
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pairs of orthogonal lines in space relative to the underlying 2D lattice were assigned randomly. 
This configuration is designed to represent point defects and the corresponding defect-induced 
strain in the crystal.
Figure 14. Surface energy distributions employed in MC simulations (a-c) and snapshots of 
MC simulations for the corresponding surface. Energy configurations represent (a) a 
defect-free crystal, (b) a crystal exhibiting a grain boundary, and (c) a crystal with 
randomly located defects and accompanying defect-induced strain. Number of MC steps 
refers to the number of trial steps of MC simulation.
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Beginning with the simplest energy configuration (Figure 14a), the snapshots reveal isotropic 
dissolution driven almost exclusively at the edges of the lattice. As expected, the crystallite seeks 
to minimize surface area by approaching a nearly circular (or spherical in 3D space) shape, as 
seen in Figure 14a-4. It can be noted, however, that the simulations deviate from circularity as 
the simulations progress, seen in Figure 14a-5 and Figure 14a-6. Most likely, this phenomenon is 
an artifact of the spatial discretization in the form of 2D Cartesian lattice sites of finite size. As 
the crystalline region shrinks, the dimensions of the lattice sites themselves influence the shape 
of the remaining domain, a consequence of forming a small circle from relatively large squares. 
In spite of this limitation, these results represent an idealized system and serve as a base case for 
comparison against more physically motivated and relevant simulations.
For the surface energy configuration in Figure 14b, the snapshots highlight interesting 
differences from those in Figure 14a. Dissolution is still driven to the edges of the lattice with a 
tendency to minimize surface area by approaching a circular shape (compare Figure 14a-4 with 
Figure 14b-5). However, the introduction of the high energy diagonal line in the surface energy 
distribution results is significant dissolution following this line. Dissolution along the diagonal 
begins forming a channel between the two halves (Figure 14b-1) which widens (Figure 14b-2) 
and eventually splits the crystal into two pieces (Figure 14b-3). These now disparate pieces each 
undergo dissolution originating at the edges and eventually working towards the center, similar 
to the dissolution for the single crystal in Figure 14a.
The final system for consideration is a more complex surface energy distribution (Figure 
14c), involving multiple localized high energy sites with high energy lines intersecting at these 
centers. Now, with significant regions of high surface energy, the initial crystal undergoes rapid 
dissolution emanating from these high energy sites/lines (Figure 14c-1,2) which leads to 
extensive channel formation (Figure 14c-3,4), and fragmentation (Figure 14c-4,5), as well as 
diffusion-based dissolution around the edges of the many resultant fragments (Figure 14c-6).
An interesting comparison between the three systems is revealed by the length of the 
simulation. While trial step count does not have a direct connection to any timescale, it is 
indicative of the relative probability of a particular dissolution event occurring. Hence, 
comparing the length of simulation to achieve a similar fractional dissolution proves to be a 
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helpful surrogate to relative rate of dissolution (Figure 15). The presence of defects and high 
energy sites shortens simulation times and thus is thought to increase the rate (probability) of 
dissolution—new surfaces are quickly exposed, which then dissolve in the typical manner. 
Moreover, by comparing the extent of dissolution in Figure 14a-2, Figure 14c-3, and Figure 14c-
6, where all three images depict simulations after 30 million trial MC steps, it is highlighted that 
the channel formation and fragmentation process is relatively rapid compared to the rate of 
diffusion-based dissolution alone.
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Figure 15. Relative extent of crystal dissolution per MC step of the three simulation 
conditions. Black diamonds represent the defect free simulation, red circles represent the 
grain boundary simulation, and blue squares represent the multiple random defects 
simulation. Error bars correspond to one standard deviation based on ten replicates for 
each simulation.
Discussion
Diffusion-Based Crystal Dissolution Model
Miscible drug-polymer systems will exhibit melting point depression, wherein the drug can 
be dissolved into the polymer at temperatures below the drug’s melting point.32,85–87 
Indomethacin and copovidone are known to have favorable specific interactions, and be miscible 
at high temperatures.32,87–91 The temperature-composition phase diagram of indomethacin and 
copovidone indicates that the solubility temperature of the composition (1:5 ratio) used in this 
investigation is approximately 78°C.32 Thus, if taken to completion at 130°C, all of the drug 
would be able to dissolve in the polymer.
Page 25 of 40
ACS Paragon Plus Environment
Crystal Growth & Design
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Page 26 of 40
The Noyes-Whitney equation coupled with the Nernst-Brunner diffusion layer model forms 
the theoretical basis for understanding the dissolution mechanism of solutes into solvents (Eq.
 sdC DA C Cdt hV   (Eq. 2)
where dC/dt is the differential change in solute concentration in solution with time, D is the 
diffusion coefficient, A is the surface area available for dissolution, Cs is the equilibrium 
solubility of the crystalline drug in the molten polymer, C is the concentration of the dissolved 
drug in the liquid phase at time t, h represents the mass transfer boundary layer thickness at the 
solid-liquid interface, and V is the volume of the liquid phase. Drug and polymer dissolution 
models can be found in the literature which incorporate particle size, particle shape, diffusion 
layer thickness, impact of other formulation components, and sink vs. non-sink conditions on 
dissolution rates into (low viscosity) solvents or biological fluids.54–56,92–96 In high viscosity 
environments, such as a polymer melt, the diffusivity of a solute molecule can be estimated by 
the Stokes-Einstein equation (Eq.
6
Bk TD
r  (Eq. 3)
where kB is the Boltzmann constant, T is the temperature, η is the viscosity, and r is the radius of 
the diffusing species. The dissolution rate is thus driven by diffusivity, temperature, viscosity, 
solubility, particle surface area, and boundary layer thickness.
Diffusion-based dissolution, schematically depicted in Figure 16a, represents the prevailing 
model for formation of a homogenous drug-polymer melt at temperatures above the polymer’s 
glass transition.31,32,40,41 First, the crystals are suspended within the polymer melt. A boundary 
layer will form on all crystal surfaces, across which the diffusing species will travel into the bulk. 
As the diffusion process proceeds, the crystal size reduces (particle shrinkage) uniformly from all 
surfaces until all crystals are completely dissolved, assuming the solubility limit has not been 
reached.
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Figure 16. Models of crystal dissolution into polymer melts: (a) diffusion-based crystal 
dissolution and (b) defect-site driven crystal dissolution and fragmentation.
The diffusion process was readily visualized by SEM-EDX mapping, by tracking the location 
of the drug’s chlorine signal. Under quiescent conditions, due to slow diffusivity in the viscous 
matrix, a gradient in chlorine signal arises on either side of a higher concentration plateau region 
(Figure 7b). The appearance of the plateau region suggests that ~30 µm was the initial width of 
the crystal being observed. Concentration, or (more accurately) activity gradients, provide the 
driving force for diffusion, whereby concentration is highest in the location of the (former) 
crystal. The driving force for diffusion decreases as the concentration gradient decreases further 
away from the crystal site. The observable gradient of molecularly dissolved indomethacin on 
each side of the plateau region is approximately 8 µm after 60 min of heating. In contrast, in the 
absence of heating, a sharp drop in chlorine content was observed, corresponding to the 
boundaries of the undissolved crystal (Figure 7a).
Defect Site-Driven Crystal Dissolution and Fragmentation Model
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In addition to diffusion, a fragmentation process has been clearly identified. This mechanism 
was first suggested through the TEM imaging and microstructure characterization performed on 
extrudates in our previous work67 and is confirmed by the study of dissolution of crystals in films 
under quiescent isothermal conditions in this study. This crystal dissolution model is 
schematically depicted in Figure 16b. Upon formation of the diffusion boundary layer, diffusion 
rates are accelerated at higher energy defect sites at the crystal surface, likely due to a greater 
thermodynamic driving force for dissolution at these sites which results in a larger concentration 
gradient for diffusion. We propose that these higher energy sites are composed of defects 
intrinsic to the crystal, or representative of the typical surface energy heterogeneity associated 
with crystal surfaces. Channels form connecting these domains, due to the faster rates of 
dissolution and the stress fields associated with the defects. This channel formation process is the 
precursor to fragmentation of the crystal. Once the channels from different areas connect, the 
parent crystal breaks apart into smaller crystallites. The channel formation and fragmentation 
process forms new surfaces available for dissolution, which then continue to dissolve by 
diffusion and/or continued fragmentation by the same mechanism. Within the hot melt extrusion 
process, the stress fields may also be sites for particle breakage due to mechanical stresses 
imposed by mixing.
The MC simulations performed aid in interpreting the experimental results and validating the 
defect site-driven crystal dissolution and fragmentation model. The base case, presented in 
Figure 14a and Figure 14d, models the diffusion-based dissolution which would govern a 
relatively ideal crystal with no significant defects or variations in surface energy. As expected, 
simulations predict global dissolution which agrees well with the diffusion-based model from 
Figure 19a. Contrasted with this ideal system are the results from two cases which depict systems 
containing two common defect types. In Figure 14b and Figure 14e, a grain boundary is shown 
to facilitate dissolution at this crystal-crystal interface, leading to fragmentation and subsequent 
diffusion-based dissolution of the resulting fragments. Similarly, localized defects and 
accompanying stress fields (Figure 14c and Figure 14f) cause rapid dissolution emanating from 
the defect sites, channel formation and fragmentation, and diffusion-based dissolution of the 
various fragmented pieces. The excellent agreement between mathematical simulation results in 
Figure 14f and the conceptual model in Figure 19b supports the usefulness of the defect site-
driven crystal dissolution and fragmentation model.
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Fragmentation was observed at all length scales by various microscopy techniques. Surface 
imperfections and growth defects were observed in some crystalline starting material (Figure 2, 
Figure 3), which is not unexpected, as such imperfections are common on the surface and in the 
bulk of organic crystals.42,43 These growth imperfections served as sites for initiation of 
dissolution due to their higher surface energy, and dissolution would be accelerated at these sites. 
By polarized light microscopy (Figure 5), these growth imperfections served as sites for 
fragmentation early in the dissolution process. However, irregular dissolution (channel and hole 
formation) was observed even in the absence of visible growth imperfections, indicating that the 
defects do not need to be on the macro-scale in order to drive surface roughening and affect the 
dissolution process. By imaging with scanning electron microscopy, the partially dissolved 
crystallites showed little similarity to the bulk crystalline starting material (Figure 6). Crystal 
surfaces were often irregular and showed evidence of heterogeneous surface dissolution and 
channel formation.
Fragmented crystals were also observed showing a range of dissolution extent under 
transmission electron microscopy. Crystals were observed dissolving uniformly from all surfaces 
(particle shrinkage) as well as by channel formation, delamination, and fragmentation (Figure 8, 
Figure 9, Figure 10b, Figure 11). As the dissolution process proceeded, heterogeneity of the 
crystal surfaces were observed (Figure 12). Isolated crystallites were observed within the overall 
crystal structure, which showed evidence of rotation and orientation changes (Figure 12). 
Evidence that isolated crystallites from a single parent crystal dissolve at fairly uniform rates was 
observed through the appearance of fragment fields, consisting of similarly sized and structured 
particles, over significant distances (Figure 13).
Implications of a Fragmentation-Based Dissolution Mechanism
Imaging crystal dissolution in a viscous matrix under quiescent isothermal conditions 
allowed the fragmentation process to be captured because of the high viscosity of and 
consequently low diffusivity within the polymeric matrix. At the temperature condition selected, 
approximately 20°C above the glass transition temperature of the polymer and 30°C below the 
melting point of the drug, the dissolution process happened over a period of hours (depending on 
the size of the initial crystal). Also, because the crystal fragments don’t move to any great extent, 
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their microstructural progression could be observed. A fragmentation-based dissolution 
mechanism may be universally found in other solute-solvent systems, although it may not be 
observed because the particles disperse under typical experimental conditions. Similar 
dissolution mechanisms and kinetics were demonstrated by Unwin and colleagues using atomic 
force microscopy (AFM) analysis of single crystals, which displayed surface roughening and 
increasing dissolution rates as dissolution progressed in an unstirred aqueous environment.2,3 
Alternatively, viscous solvents (e.g. polyethylene glycols, lipids, polymers) may have unique 
properties that bring about this mechanism.
Because of the exposure of new surfaces, fragmentation may enable dissolution to proceed 
more rapidly. Detection of the crystalline phase may also be hindered by the fragmentation 
process. For example, in powder x-ray diffraction, reduction in signal intensity due to decreased 
crystalline content and peak broadening due to decreased crystallite size (particularly into the 
low nanometer range) limit the detection of low levels of crystallinity.73–75 In this system, the 
crystalline phase was detected through 2 hours by high temperature XRD (Figure 4), although 
crystals were observed by all microscopy techniques at longer dissolution times. Ultimately, the 
use of methods such as XRD may lead to an incorrect conclusion that the phase transformation is 
complete.
Application to Hot Melt Extrusion Process Modeling & Design
Modeling of HME is complex and has mainly focused on mass, energy, and momentum 
balances.97 Recently, a HME process model has been developed which assumes a consistent 
number of particles and corresponding reduction of surface area during dissolution, and links 
process parameters with ASD formation.98 The consideration of a fragmentation-based 
dissolution mechanism indicates that the number of particles, and thus surface area, may change 
during the dissolution process. A population balance-type model with a changing number of 
particles, due to both phase transformation and fragmentation, is therefore likely necessary to 
accurately capture the dynamics of the dissolution process.
Mechanical damage serves as a complementary source of lattice defects and particle 
breakage, which would accelerate the formation of dissolution surfaces. Mechanically-induced 
defects or particle breakage may arise due to mixing in the extruder.32,67 Such mechanical 
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contributions would be expected to have a significant impact on the dissolution mechanism of 
crystals within a hot melt extrusion process, particularly with screw configurations consisting of 
dispersive mixing/kneading elements.
Particle size distribution is known to play a significant kinetic role in a hot melt extrusion 
process.30,32 The identification of a fragmentation mechanism driven by defects further suggests 
that it is critical to have control of the crystal quality (i.e. defect density), in addition to the 
particle size distribution of the starting crystalline material, in order to have adequate control of 
an HME process. A crystallization process which produces particles with higher defect density 
yields a faster dissolution rate, as demonstrated by Burt and Mitchell.48 Our work would further 
suggest that these defects served as sites for initiation of fragmentation, yielding more surfaces 
for dissolution, thus increasing dissolution rate.
Conclusion
A fragmentation-based mechanism for dissolution of organic crystals into a polymer melt 
was identified based on microscopic observation under multiple length scales. Defects intrinsic 
to the crystal, or induced by mechanical means, are hypothesized to be the sites of initiation of 
the crystal dissolution process. Stress fields from these defect sites further accelerate the 
dissolution process, forming channels and ultimately fragmenting the parent crystal into smaller 
crystallites. This fragmentation-based mechanism has implications for modeling of crystal 
dissolution into polymer melts, since the number of crystalline particles may change during the 
phase transformation, and not all surfaces may dissolve uniformly. In addition to the particle size 
distribution and corresponding available surface area for dissolution, the presence of intrinsic 
and induced defects affects the dissolution rate. Thus, crystal quality may be an unexplored 
critical material attribute.
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